Annual Cash & Cash Equivalents
$754.10 K
-$3.86 M-83.67%
December 31, 2023
Summary
- As of February 7, 2025, MRM annual cash & cash equivalents is $754.10 thousand, with the most recent change of -$3.86 million (-83.67%) on December 31, 2023.
- During the last 3 years, MRM annual cash & cash equivalents has fallen by -$13.21 million (-94.60%).
- MRM annual cash & cash equivalents is now -94.60% below its all-time high of $13.96 million, reached on December 31, 2020.
Performance
MRM Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$898.80 K
+$144.70 K+19.19%
June 30, 2024
Summary
- As of February 7, 2025, MRM quarterly cash and cash equivalents is $898.80 thousand, with the most recent change of +$144.70 thousand (+19.19%) on June 30, 2024.
- Over the past year, MRM quarterly cash and cash equivalents has increased by +$85.80 thousand (+10.55%).
- MRM quarterly cash and cash equivalents is now -93.56% below its all-time high of $13.96 million, reached on December 31, 2020.
Performance
MRM Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MRM Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -83.7% | +10.6% |
| 3 y3 years | -94.6% | +21.9% |
| 5 y5 years | -60.7% | - |
MRM Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -83.7% | at low | -80.5% | +21.9% |
| 5 y | 5-year | -94.6% | at low | -93.6% | +21.9% |
| alltime | all time | -94.6% | at low | -93.6% | +21.9% |
MEDIROM Healthcare Technologies Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $898.80 K(+19.2%) |
| Dec 2023 | $754.10 K(-83.7%) | $754.10 K(-7.2%) |
| Jun 2023 | - | $813.00 K(-82.4%) |
| Dec 2022 | $4.62 M(+43.4%) | $4.62 M(+526.2%) |
| Jun 2022 | - | $737.40 K(-77.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $3.22 M(-76.9%) | $3.22 M(+0.3%) |
| Jun 2021 | - | $3.21 M(-77.0%) |
| Dec 2020 | $13.96 M(+196.0%) | $13.96 M(+567.4%) |
| Jun 2020 | - | $2.09 M(-55.7%) |
| Dec 2019 | $4.72 M(+145.9%) | $4.72 M |
| Dec 2018 | $1.92 M | - |
FAQ
- What is MEDIROM Healthcare Technologies annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for MEDIROM Healthcare Technologies?
- What is MEDIROM Healthcare Technologies annual cash & cash equivalents year-on-year change?
- What is MEDIROM Healthcare Technologies quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for MEDIROM Healthcare Technologies?
- What is MEDIROM Healthcare Technologies quarterly cash and cash equivalents year-on-year change?
What is MEDIROM Healthcare Technologies annual cash & cash equivalents?
The current annual cash & cash equivalents of MRM is $754.10 K
What is the all time high annual cash & cash equivalents for MEDIROM Healthcare Technologies?
MEDIROM Healthcare Technologies all-time high annual cash & cash equivalents is $13.96 M
What is MEDIROM Healthcare Technologies annual cash & cash equivalents year-on-year change?
Over the past year, MRM annual cash & cash equivalents has changed by -$3.86 M (-83.67%)
What is MEDIROM Healthcare Technologies quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of MRM is $898.80 K
What is the all time high quarterly cash and cash equivalents for MEDIROM Healthcare Technologies?
MEDIROM Healthcare Technologies all-time high quarterly cash and cash equivalents is $13.96 M
What is MEDIROM Healthcare Technologies quarterly cash and cash equivalents year-on-year change?
Over the past year, MRM quarterly cash and cash equivalents has changed by +$85.80 K (+10.55%)